Welcome to the Theralase Technologies Marketing Hub On AGORACOM

Click "edit fast facts" to make changes

Free
Message: Theralase Demonstrates Anti-Cancer Technology Prevents Recurrence of Bladder Cancer at 180 Days Post-Treatment
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Beats me why this sits at around 35-40 cents. 

They have sucessfully treated 6 patients past the 180 day mark and will now move on to the next appoval stage.

This treatment is not bladder specific and will be tested/utilized on other types of cancer. 

This seems to  me to be a stock waiting to explode by growth or takeoever.

All IMHO

Wishing

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply